Rezultati pretraživanja
  1. New article: [Pulmonary infiltration of acute monoblastic leukemia diagnosed by transbronchial lung biopsy].

  2. New article: More than ten percent of relapses occur after five years in AML patients with NPM1 mutation.

  3. New article: "Harnessing the Immune System After Allogeneic Stem Cell Transplant in Acute Myeloid Leukemia".

  4. New article: Don't be fooled by the fat: A rare case of renal cell carcinoma with intratumoural fat.

  5. New article: H3K36me3, message from chromatin to DNA damage repair.

  6. New article: Profile of Quizartinib for the Treatment of Adult Patients with Relapsed/Refractory FLT3-ITD-Positive Acute Myeloid Leukemia: Evidence to Date.

  7. New article: Urgent Chemotherapy Successfully Rescues a Near Death Patient of Acute Intracranial Hypertension Caused by Intracranial Myeloid Sarcoma.

  8. New article: Curcumin Combined with Thalidomide Reduces Expression of STAT3 and Bcl-xL, Leading to Apoptosis in Acute Myeloid Leukemia Cell Lines.

  9. New article: Allogeneic stem cell transplantation in AML with t(6;9)(p23;q34);DEK-NUP214 shows a favourable outcome when performed in first complete remission.

  10. New article: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 4.2020, NCCN Clinical Practice Guidelines in Oncology.

  11. New article: Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors.

  12. New publication shows CAR NK cells induce high response rates in patients with R/R CD19 positive lymphoid malignancies. Will CAR NK cells also prove efficacious for ?

  13. prije 3 sata
  14. prije 9 sati
    Odgovor korisniku/ci

    They’re meant to be pre-treatment risk categories. That said, acquiring RUNX1 mutation later is likely also a bad prognostic sign (since it usually means the patient has relapsed or is not responding to therapy i.e still clonally evolving.

  15. New article: Serum levels of hsa-miR-16-5p, -29a-3p, -150-5p, -155-5p and -223-3p and subsequent risk of chronic lymphocytic leukemia in the EPIC study.

  16. New article: The expanding role of venetoclax in chronic lymphocytic leukemia and small lymphocytic lymphoma.

  17. New article: Trametinib and Dabrafenib in histiocytic sarcoma transdifferentiated from chronic lymphocytic leukemia with a K-RAS and a unique BRAF mutation.

  18. New article: Efficacy of mitoxantrone-based salvage therapies in relapsed or refractory acute myeloid leukemia in the Mayo Clinic Cancer Center: Analysis of survival after 'CLAG-M' vs. 'MEC'.

  19. New article: DNMT3A mutants provide proliferating advantage with augmentation of self-renewal activity in the pathogenesis of AML in KMT2A-PTD-positive leukemic cells.

  20. In case you missed it | Which abstracts from will change clinical practice in AML? Our Steering Committee provided their opinions on the practice-changing abstracts presented, available here as a free downloadable resource:

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.